ctrl K

Watchlist Price Alert

BioPlus Acquisition Corp. (BIOSW)

NASDAQ: BIOSW · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Oct 06, 2023, 7:56 PM

BioPlus Acquisition Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2022	FY 2021	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	708.9M	817.2M	935.6M
Cost of Revenue	1.17M	n/a	465.9M	547.9M	670M
Gross Profit	-1.17M	n/a	243M	269.3M	265.6M
Operating Income	-1.17M	-162.43	-108.5M	-52.7M	-77.7M
Interest Income	3.17M	9.49	n/a	n/a	n/a
Pretax Income	2M	-152.94	-51M	-67.4M	-32.4M
Net Income	5.16M	-152.94	-51.6M	-131M	-34.4M
Selling & General & Admin	1.17K	162.43	47.3M	63.3M	66M
Research & Development	n/a	n/a	n/a	n/a	n/a
Other Expenses	1.17M	n/a	189.6M	220.8M	197.7M
Operating Expenses	1.17M	162.43	236.9M	284.1M	263.7M
Interest Expense	n/a	n/a	-57.4M	-52.1M	-38.2M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.17M	162.43	702.8M	832M	933.7M
Income Tax Expense	-3.17M	9.49	600K	63.6M	2M
Shares Outstanding (Basic)	597.79M	6.88K	127.9M	123.8M	93.7M
Shares Outstanding (Diluted)	597.79M	6.88K	127.9M	123.8M	93.7M
EPS (Basic)	0.01	-0.02	-0.4	-1.06	-0.37
EPS (Diluted)	0.01	-0.02	-0.4	-1.06	-0.37
EBITDA	-1.17M	9.49	-84.9M	-24.97M	-56.15M
EBIT	n/a	n/a	-108.4M	-119.5M	-70.6M
Depreciation & Amortization	228.49K	236.56K	23.6M	27.73M	21.55M